- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07708402
Healing Stigma Through Stories
Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia
This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia.
A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Li-Ting Huang, phD
- Telefonnummer: +8862-28267284
- E-post: lthuang@nycu.edu.tw
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Aged 18 years or older.
- Diagnosed with schizophrenia or schizoaffective disorder.
- Clinically stable at the time of study enrollment.
- Able to communicate in Mandarin Chinese or Taiwanese.
- Able to read and write and complete study questionnaires.
Exclusion Criteria:
- Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
- Unwilling to have the intervention sessions audio-recorded.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Healing Stigma through Stories
|
Four group sessions and four individual sessions, held once a week for a total of eight weeks.
The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
The Internalized Stigma of Mental Illness Scale
Tidsram: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Beck Depression Inventory-II
Tidsram: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
Self-Reported Graphic version of the Personal and Social Performance Scale
Tidsram: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
Subjective Happiness Scale
Tidsram: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
Herth Hope Index
Tidsram: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
The questionnaire about the process of recovery
Tidsram: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- NYCU115040AF
- 115-2314-B-A49 -082 - (Annat bidrag/finansieringsnummer: National Science and Technology Council)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .